BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23506265)

  • 1. Psyllium: a promising polymer for sustained release formulations in combination with HPMC polymers.
    Kaialy W; Emami P; Asare-Addo K; Shojaee S; Nokhodchi A
    Pharm Dev Technol; 2014 May; 19(3):269-77. PubMed ID: 23506265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers.
    Siahi-Shadbad MR; Asare-Addo K; Azizian K; Hassanzadeh D; Nokhodchi A
    AAPS PharmSciTech; 2011 Dec; 12(4):1176-82. PubMed ID: 21918920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
    Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
    Chakraborty S; Khandai M; Sharma A; Patra ChN; Patro VJ; Sen KK
    Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified drug release of poloxamer matrix by including water-soluble and water-insoluble polymer.
    Gonzalez YM; Ghaly ES
    Drug Dev Ind Pharm; 2010 Jan; 36(1):64-71. PubMed ID: 19747067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
    Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets.
    Asnaashari S; Khoei NS; Zarrintan MH; Adibkia K; Javadzadeh Y
    Pharm Dev Technol; 2011 Aug; 16(4):400-7. PubMed ID: 20429828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
    Chen L; Wang F
    Pharmazie; 2013 Oct; 68(10):796-9. PubMed ID: 24273882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1167-74. PubMed ID: 22540355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.
    Kim H; Fassihi R
    J Pharm Sci; 1997 Mar; 86(3):323-8. PubMed ID: 9050800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
    Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
    Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution.
    Escudero JJ; Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2010 Mar; 387(1-2):56-64. PubMed ID: 19969052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
    Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
    Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Plantago major L. seed mucilage as a rate controlling matrix for sustained release of propranolol hydrochloride.
    Saeedi M; Morteza-Semnani K; Sagheb-Doust M
    Acta Pharm; 2013 Mar; 63(1):99-114. PubMed ID: 23482316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices.
    Nokhodchi A; Hassan-Zadeh D; Monajjem-Zadeh F; Taghi-Zadeh N
    Acta Pharm; 2008 Jun; 58(2):151-62. PubMed ID: 18515225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hydroxypropyl methylcellulose on drug release pattern of a gastroretentive floating drug delivery system using a 3(2) full factorial design.
    Swain K; Pattnaik S; Mallick S; Chowdary KA
    Pharm Dev Technol; 2009; 14(2):193-8. PubMed ID: 19519191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.